CEUAX
Price
$66.07
Change
-$0.53 (-0.80%)
Updated
Jun 3 closing price
Net Assets
136.57B
GONCX
Price
$37.48
Change
+$0.23 (+0.62%)
Updated
Jun 2 closing price
Net Assets
6.37B
Interact to see
Advertisement

CEUAX vs GONCX

Header iconCEUAX vs GONCX Comparison
Open Charts CEUAX vs GONCXBanner chart's image
CEUAX vs GONCX Comparison Chart in %
View a ticker or compare two or three
VS
CEUAX vs. GONCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEUAX is a Hold and GONCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CEUAX has more cash in the bank: 137B vs. GONCX (6.37B). CEUAX pays higher dividends than GONCX: CEUAX (2.51) vs GONCX (0.00). CEUAX was incepted earlier than GONCX: CEUAX (24 years) vs GONCX (20 years). GONCX (2.00) is less costly to investors than CEUAX (0.85). GONCX is a more actively managed with annual turnover of: 65.00 vs. CEUAX (35.00). CEUAX has a lower initial minimum investment than GONCX: CEUAX (250) vs GONCX (1000). GONCX annual gain was more profitable for investors over the last year : 25.17 vs. CEUAX (15.70). CEUAX return over 5 years is better than : -1.09 vs. GONCX (-2.89).
CEUAXGONCXCEUAX / GONCX
Total Expense Ratio0.852.0043%
Annual Report Gross Expense Ratio0.852.0043%
Fund Existence24 years20 years-
Gain YTD12.15913.39491%
Front Load4%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets137B6.37B2,150%
Annual Yield % from dividends2.510.00-
Returns for 1 year15.7025.1762%
Returns for 3 years32.4866.2949%
Returns for 5 years-1.09-2.8938%
Returns for 10 years68.7577.9188%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCSG20.240.30
+1.50%
Healthcare Services Group
SONY22.790.22
+0.97%
Sony Group Corporation
LNTH96.30-0.83
-0.85%
Lantheus Holdings
AWRE1.47-0.03
-2.00%
Aware
ELDN3.53-0.23
-6.12%
Eledon Pharmaceuticals